|
1
|
Stoyanov GS and Dzhenkov DL: On the
concepts and history of glioblastoma multiforme-morphology,
genetics and epigenetics. Folia Med (Plovdiv). 60:48–66. 2018.
View Article : Google Scholar
|
|
2
|
Louis DN, Perry A, Reifenberger G, Von DA,
Figarellabranger D, Cavenee WK, Ohgaki H, Wiestler OD, Kleihues P
and Ellison DW: The 2016 World Health Organization classification
of tumors of the central nervous system: A summary. Acta
Neuropathol. 131:803–820. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Ostrom QT, Gittleman H, Liao P, Rouse C,
Chen Y, Dowling J, Wolinsky Y, Kruchko C and Barnholtz-Sloan J:
CBTRUS statistical report: Primary brain and central nervous system
tumors diagnosed in the United States in 2007–2011. Neuro Oncol.
16(Suppl 4): iv1–iv63. 2014. View Article : Google Scholar :
|
|
4
|
Stupp R, Mason WP, van den Bent MJ, Weller
M, Fisher B, Taphoorn MJ, Belanger K, Brandes AA, Marosi C, Bogdahn
U, et al: Radiotherapy plus concomitant and adjuvant temozolomide
for glioblastoma. N Engl J Med. 352:987–996. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Khasraw M, Ameratunga MS, Grant R, Wheeler
H and Pavlakis N: Antiangiogenic therapy for high-grade glioma.
Cochrane Database Syst Rev. CD0082182014.PubMed/NCBI
|
|
6
|
Weller M, Butowski N, Tran DD, Recht LD,
Lim M, Hirte H, Ashby L, Mechtler L, Goldlust SA, Iwamoto F, et al:
Rindopepimut with temozolomide for patients with newly diagnosed,
EGFRvIII-expressing glioblastoma (ACT IV): A randomised,
double-blind, international phase 3 trial. Lancet Oncol.
18:1373–1385. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Yan W, Zhang W, You G, Zhang J, Han L, Bao
Z, Wang Y, Liu Y, Jiang C, Kang C, et al: Molecular classification
of gliomas based on whole genome gene expression: A systematic
report of 225 samples from the Chinese Glioma Cooperative Group.
Neuro Oncol. 14:1432–1440. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Langfelder P and Horvath S: WGCNA: An R
package for weighted correlation network analysis. BMC
Bioinformatics. 9:5592008. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Lv B, Zhang L, Miao R, Xiang X, Dong S,
Lin T, Li K and Qu K: Comprehensive analysis and experimental
verification of LINC01314 as a tumor suppressor in hepatoblastoma.
Biomed Pharmacother. 98:783–792. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Clarke C, Madden SF, Doolan P, Aherne ST,
Joyce H, O'Driscoll L, Gallagher WM, Hennessy BT, Moriarty M, Crown
J, et al: Correlating transcriptional networks to breast cancer
survival: A large-scale coexpression analysis. Carcinogenesis.
34:2300–2308. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Liu XY, Gerges N, Korshunov A, Sabha N,
Khuong-Quang DA, Fontebasso AM, Fleming A, Hadjadj D,
Schwartzentruber J, Majewski J, et al: Frequent ATRX mutations and
loss of expression in adult diffuse astrocytic tumors carrying
IDH1/IDH2 and TP53 mutations. Acta Neuropathol. 124:615–625. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Brennan CW, Verhaak RG, McKenna A, Campos
B, Noushmehr H, Salama SR, Zheng S, Chakravarty D, Sanborn JZ,
Berman SH, et al: The somatic genomic landscape of glioblastoma.
Cell. 155:462–477. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Ashburner M, Ball CA, Blake JA, Botstein
D, Butler H, Cherry JM, Davis AP, Dolinski K, Dwight SS, Eppig JT,
et al: Gene ontology: Tool for the unification of biology. The Gene
Ontology Consortium. Nat Genet. 25:25–29. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Kanehisa M: The KEGG database. Novartis
Found Symp. 247:91–101; discussion 101–103, 119–128, 244–152. 2002.
View Article : Google Scholar
|
|
15
|
Mi H, Dong Q, Muruganujan A, Gaudet P,
Lewis S and Thomas PD: PANTHER version 7: Improved phylogenetic
trees, orthologs and collaboration with the Gene Ontology
Consortium. Nucleic Acids Res. 38(Database Issue): D204–D210. 2010.
View Article : Google Scholar
|
|
16
|
Szklarczyk D, Franceschini A, Wyder S,
Forslund K, Heller D, Huerta-Cepas J, Simonovic M, Roth A, Santos
A, Tsafou KP, et al: STRING v10: Protein-protein interaction
networks, integrated over the tree of life. Nucleic Acids Res.
43(Database Issue): D447–D452. 2015. View Article : Google Scholar
|
|
17
|
Shannon P, Markiel A, Ozier O, Baliga NS,
Wang JT, Ramage D, Amin N, Schwikowski B and Ideker T: Cytoscape: A
software environment for integrated models of biomolecular
interaction networks. Genome Res. 13:2498–2504. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Tang Z, Li C, Kang B, Gao G, Li C and
Zhang Z: GEPIA: A web server for cancer and normal gene expression
profiling and interactive analyses. Nucleic Acids Res. 45:W98–W102.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
McLean CY, Bristor D, Hiller M, Clarke SL,
Schaar BT, Lowe CB, Wenger AM and Bejerano G: GREAT improves
functional interpretation of cis-regulatory regions. Nat
Biotechnol. 28:495–501. 2010. View
Article : Google Scholar : PubMed/NCBI
|
|
20
|
Pagliarini R, Shao W and Sellers WR:
Oncogene addiction: Pathways of therapeutic response, resistance,
and road maps toward a cure. EMBO Rep. 16:280–296. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Yang F, Shen Y, Zhang W, Jin J, Huang D,
Fang H, Ji W, Shi Y, Tang L, Chen W, et al: An androgen receptor
negatively induced long non-coding RNA ARNILA binding to miR-204
promotes the invasion and metastasis of triple-negative breast
cancer. Cell Death Differ. 25:2209–2220. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Wong N and Wang X: miRDB: An online
resource for microRNA target prediction and functional annotations.
Nucleic Acids Res. 43(Database Issue): D146–D152. 2015. View Article : Google Scholar :
|
|
23
|
Mai WX, Gosa L, Daniels VW, Ta L, Tsang
JE, Higgins B, Gilmore WB, Bayley NA, Harati MD, Lee JT, et al:
Cytoplasmic p53 couples oncogene-driven glucose metabolism to
apoptosis and is a therapeutic target in glioblastoma. Nat Med.
23:1342–1351. 2017.PubMed/NCBI
|
|
24
|
Hu B, Wang Q, Wang YA, Hua S, Sauvé CG,
Ong D, Lan ZD, Chang Q, Ho YW, Monasterio MM, et al: Epigenetic
Activation of WNT5A drives glioblastoma stem cell differentiation
and invasive growth. Cell. 167:1281–1295.e18. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Furnari FB, Cloughesy TF, Cavenee WK and
Mischel PS: Heterogeneity of epidermal growth factor receptor
signalling networks in glioblastoma. Nat Rev Cancer. 15:302–310.
2015. View
Article : Google Scholar : PubMed/NCBI
|
|
26
|
Guan X, Zhang C, Zhao J, Sun G, Song Q and
Jia W: CMTM6 overexpression is associated with molecular and
clinical characteristics of malignancy and predicts poor prognosis
in gliomas. EBioMedicine. 35:233–243. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Wanibuchi M, Ohtaki S, Ookawa S,
Kataoka-Sasaki Y, Sasaki M, Oka S, Kimura Y, Akiyama Y, Mikami T,
Mikuni N, et al: Actin, alpha, cardiac muscle 1 (ACTC1) knockdown
inhibits the migration of glioblastoma cells in vitro. J Neurol
Sci. 392:117–121. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Loriguet L, Morisse MC, Dremaux J, Collet
L, Attencourt C, Coutte A, Boone M, Sevestre H, Galmiche A, Gubler
B, et al: Combining genomic analyses with tumour-derived slice
cultures for the characterization of an EGFR-activating kinase
mutation in a case of glioblastoma. BMC Cancer. 18(964): 2108
|
|
29
|
Busche S, Ge B, Vidal R, Spinella JF,
Saillour V, Richer C, Healy J, Chen SH, Droit A, Sinnett D and
Pastinen T: Integration of high-resolution methylome and
transcriptome analyses to dissect epigenomic changes in childhood
acute lymphoblastic leukemia. Cancer Res. 73:4323–4336. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Parikshak NN, Luo R, Zhang A, Won H, Lowe
JK, Chandran V, Horvath S and Geschwind DH: Integrative functional
genomic analyses implicate specific molecular pathways and circuits
in autism. Cell. 155:1008–1021. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Cruchaga C, Karch CM, Jin SC, Benitez BA,
Cai Y, Guerreiro R, Harari O, Norton J, Budde J, Bertelsen S, et
al: Rare coding variants in the phospholipase D3 gene confer risk
for Alzheimer's disease. Nature. 505:550–554. 2014. View Article : Google Scholar
|
|
32
|
Nakada M, Nakada S, Demuth T, Tran NL,
Hoelzinger DB and Berens ME: Molecular targets of glioma invasion.
Cell Mol Life Sci. 64:458–78. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Charles NA, Holland EC, Gilbertson R,
Glass R and Kettenmann H: The brain tumor microenvironment. Glia.
60:502–514. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Vargová L, Homola A, Zámecník J, Tichý M,
Benes V and Syková E: Diffusion parameters of the extracellular
space in human gliomas. Glia. 42:77–88. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Klank RL, Decker Grunke SA, Bangasser BL,
Forster CL, Price MA, Odde TJ, SantaCruz KS, Rosenfeld SS, Canoll
P, Turley EA, et al: Biphasic dependence of glioma survival and
cell migration on CD44 expression level. Cell Rep. 18:23–31. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Kwiatkowska A and Symons M: Signaling
determinants of glioma cell invasion. Adv Exp Med Biol.
986:121–141. 2013. View Article : Google Scholar
|
|
37
|
Liu Y, Carson-Walter EB, Cooper A, Winans
BN, Johnson MD and Walter KA: Vascular gene expression patterns are
conserved in primary and metastatic brain tumors. J Neurooncol.
99:13–24. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Mikheeva SA, Mikheev AM, Petit A, Beyer R,
Oxford RG, Khorasani L, Maxwell JP, Glackin CA, Wakimoto H,
González-Herrero I, et al: TWIST1 promotes invasion through
mesenchymal change in human glioblastoma. Mol Cancer. 9:1942010.
View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Pankov R and Yamada KM: Fibronectin at a
glance. J Cell Sci. 115:3861–3863. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
DeLay M, Jahangiri A, Carbonell WS, Hu YL,
Tsao S, Tom MW, Paquette J, Tokuyasu TA and Aghi MK: Microarray
analysis verifies two distinct phenotypes of glioblastomas
resistant to antiangiogenic therapy. Clin Cancer Res. 18:2930–2942.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Janiszewska M, Suvà ML, Riggi N,
Houtkooper RH, Auwerx J, Clément-Schatlo V, Radovanovic I, Rheinbay
E, Provero P and Stamenkovic I: Imp2 controls oxidative
phosphorylation and is crucial for preserving glioblastoma cancer
stem cells. Genes Dev. 26:1926–1944. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Dimroth P, Kaim G and Matthey U: Crucial
role of the membrane potential for ATP synthesis by F(1)F(o) ATP
synthases. J Exp Biol. 203:51–59. 2000.
|
|
43
|
Feichtinger RG, Weis S, Mayr JA,
Zimmermann F, Geilberger R, Sperl W and Kofler B: Alterations of
oxidative phosphorylation complexes in astrocytomas. Glia.
62:514–525. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Kennedy CR, Tilkens SB, Guan H, Garner JA,
Or PM and Chan AM: Differential sensitivities of glioblastoma cell
lines towards metabolic and signaling pathway inhibitions. Cancer
Lett. 336:299–306. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Balbous A, Cortes U, Guilloteau K,
Villalva C, Flamant S, Gaillard A, Milin S, Wager M, Sorel N,
Guilhot J, et al: A mesen-chymal glioma stem cell profile is
related to clinical outcome. Oncogenesis. 3:e912014. View Article : Google Scholar
|
